Sally Beauty (SBH) analyst forecast and price target
Analyst forecast
Consensus of 5 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| TD Cowen | Maintained | Buy | $19.00 from $17.00 | Aug 4, 2026 |
| Morgan Stanley | Maintained | Underweight | $13.00 from $16.00 | May 12, 2026 |
| TD Cowen | Maintained | Buy | $17.00 from $20.00 | May 12, 2026 |
| Morgan Stanley | Maintained | Underweight | $16.00 from $14.00 | Feb 10, 2026 |
| Canaccord Genuity | Maintained | Buy | $20.00 from $19.00 | Feb 10, 2026 |
| Raymond James | Upgraded | Market Perform → Outperform | $19.00 | Jan 21, 2026 |
| TD Cowen | Maintained | Buy | $18.00 from $17.00 | Jan 21, 2026 |
| Jefferies | Initiated Coverage | Hold | $16.00 | Jan 14, 2026 |
| Morgan Stanley | Maintained | Underweight | $13.00 from $10.00 | Nov 14, 2025 |
| Jefferies | Maintained | Hold | $14.50 from $12.80 | Oct 28, 2025 |
| Canaccord Genuity | Maintained | Buy | $19.00 from $15.00 | Sep 15, 2025 |
| TD Cowen | Maintained | Buy | $16.00 from $13.00 | Sep 4, 2025 |
| Canaccord Genuity | Maintained | Buy | $15.00 from $14.00 | Aug 6, 2025 |
| DA Davidson | Maintained | Neutral | $10.50 from $13.00 | Feb 18, 2025 |
| Morgan Stanley | Maintained | Underweight | $10.00 from $12.00 | Jan 21, 2025 |
| Canaccord Genuity | Initiated Coverage | Buy | $14.00 | Jan 16, 2025 |
| TD Cowen | Upgraded | Hold → Buy | $16.00 from $14.00 | Nov 25, 2024 |
| Morgan Stanley | Maintained | Underweight | $12.00 from $8.00 | Nov 15, 2024 |
| Raymond James | Upgraded | Underperform → Market Perform | — | Nov 15, 2024 |
| DA Davidson | Maintained | Neutral | $13.00 from $12.00 | Nov 15, 2024 |
Frequently asked questions
Is SBH a buy, sell, or hold?
Analysts covering Sally Beauty currently average a Buy rating: 3 buy, 1 hold and 1 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on SBH?
On Aug 4, 2026, TD Cowen maintained Sally Beauty at Buy with a price target of $19.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.